One way to almost fill a gap, however most unexpected to do it this way. European approval for Ahlzheimers now becomes of major importance. 5.77 is the actual closing number so .02 still open. Any thoughts on whether the trial was not set up as tight as it could have been? Hmmm.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.